Hims & Hers Health, Inc.

Hims & Hers Health, Inc. runs a consumer-first digital health platform that connects patients to licensed clinicians, online prescriptions, and pharmacy fulfillment. Founded in 2017, it focuses on routine and recurring care areas such as sexual health, hair loss, hormone health, weight loss, dermatology, mental health, and lab testing, delivered through its websites and mobile apps.

6,8 %

73,8 %

5,5 %

+59,0 %

1.90

1.70

— Hims & Hers Health, Inc.
%
Prescription telehealth treatments70% Condition-specific online consultations, clinician visits, and prescription therapies fulfilled through the platform.
Non-prescription wellness products10% Over-the-counter and wellness products sold directly to consumers through digital and retail channels.
Laboratory testing and diagnostics8% At-home or facilitated lab testing used to support diagnosis, treatment selection, and follow-up care.
Pharmacy and fulfillment services7% Cloud-enabled dispensing, packaging, and shipping services that support recurring treatment delivery.
Platform access and care services5% Digital care infrastructure, follow-up support, and app-based health content that improve retention and engagement.

The company sells directly to consumers who want convenient, private, and lower-friction access to care for sensitive...

  • Direct-to-consumer prescription patientsprimary

    Buy clinician-guided prescription treatments for sexual health, hair loss, weight loss, dermatology, hormone health, and mental health because the platform is private and convenient.

  • Subscription-based recurring care usersprimary

    Purchase ongoing treatment plans and refills through the app because the model supports continuity, follow-up, and convenience.

  • Non-prescription wellness shopperssecondary

    Buy over-the-counter health and wellness products for self-directed care and everyday maintenance.

  • Lab testing and diagnostics userssecondary

    Order testing to support diagnosis, treatment selection, and monitoring for conditions managed on the platform.

  • Retail channel consumersemerging

    Purchase non-prescription products in U.S. retail locations, extending the brand beyond the app ecosystem.

Hims & Hers serves customers in the United States, Canada, the United Kingdom, and parts of the European Union,...

  • United States is the core market and main demand base
  • Canada and the UK extend the digital health platform internationally
  • EU presence includes Germany, Ireland, France, and Spain
  • Regulatory differences shape product launch speed and operating model
  • International expansion can diversify growth but adds compliance complexity

The company is focused on expanding customer acquisition, increasing cross-sell within its existing base, and...

01
Customer acquisition at scaleshort-term

Growth depends on continuously bringing new users onto the platform at acceptable marketing returns.

02
Expand within the existing customer basemedium-term

Cross-sell and subscription retention improve lifetime value and reduce reliance on new-user growth.

03
Broaden clinical and product capabilitiesmedium-term

More conditions and services increase platform relevance and make the brand harder to replace.

04
Selective acquisitions and international expansionlong-term

Acquired platforms and new geographies can add users, capabilities, and long-term revenue pools.

The business depends heavily on digital marketing efficiency, platform trust, and the ability to retain customers in a...

high

Cybersecurity and data privacy breaches

The platform stores and transmits sensitive patient information and relies on third parties for key functions.

Scope
Customer and patient data, cloud systems, vendor infrastructure
Materiality
high
high

Marketing inefficiency and customer acquisition slowdown

Revenue depends on continuously enrolling new customers at acceptable returns on marketing spend.

Scope
Direct-to-consumer demand generation
Materiality
high
high

Regulatory changes affecting telehealth, prescriptions, and compounding

The company operates in a heavily regulated healthcare and pharmaceutical environment.

Scope
FDA rules, state and federal telehealth laws, pharmacy operations
Materiality
high
medium

Competition from digital health, pharmacies, and traditional providers

The company competes against both niche digital rivals and larger healthcare organizations.

Scope
Sexual health, weight loss, dermatology, mental health, lab testing
Materiality
medium
medium

Execution risk from acquisitions and international expansion

New platforms and geographies can increase operating complexity before benefits are realized.

Scope
Integration, compliance, and operating expense growth
Materiality
medium
Revenue recognition for subscription prescriptions and services
Quarterly revenue comparability and deferred revenue balances
Inventory valuation
Gross margin and inventory write-down risk
Stock-based compensation
Operating expenses and diluted share count
Business combination fair values and contingent consideration
Goodwill, intangible assets, and future expense volatility
Lease and cloud software commitments
Fixed obligations and cash flow visibility

: 28.4.2026